RISVUTATUG
UNII N7PS484DJN

Substance Identification & Data

This profile provides standardized clinical and technical data for Risvutatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N7PS484DJN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3042848-87-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N7PS484DJN
CAS Registry Number
3042848-87-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RISVUTATUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224786
National Cancer Institute reference terminology for clinical and research data.
INN ID
13783
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Risvutatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RISVUTATUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-449) (VH (HOMO SAPIENS IGHV3-30*01 (94.9%) -(IGHD) -IGHJ4*01 (92.9%) T122>A (113), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 D12 (358), L14 (360) (343-447), CHS (448-449)) (120-449)), (222-215')-DISULFIDE WITH L-LAMBDA1 LIGHT CHAIN HOMO SAPIENS (1'-215') (V-LAMBDA (HOMO SAPIENS IGLV8-61*01 (89.7%) -IGLJ3*02 (100%), CDR-IMGT (9.3.10) (26'-34'.52'-54'.91'-100')) (1'-110') -HOMO SAPIENS IGLC1*02 (100%) (C-LAMBDA1 S127>DEL) (111'-215')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN B7 HOMOLOG PROTEIN B7H3) (HUMAN MONOCLONAL GSK5764224 .GAMMA.-CHAIN), DISULFIDE WITH (DE-C-TERMINAL-SERINE) HUMAN MONOCLONAL GSK5764224 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS CD276 (B7H3, B7-H3, B7-RELATED PROTEIN 2, B7RP2, B7RP-2, B7 HOMOLOG 3, B7 HOMOLOGUE 3)), HOMO SAPIENS MONOCLONAL ANTIBODY (RISVUTATUG)
RISVUTATUG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus